Lucas Scardua Silva

Lucas Scardua Silva

Auto-generated profile, based on publicly available information

Lucas Scardua Silva

Neuroimaging Laboratory, Department of Neurology, University of Campinas-UNICAMP, Campinas, SP, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2020 in medRxiv
Verified
Preprint
Open access
PDF file
FCFernanda Crunfli
Fernanda Crunfli
VCVictor Carregari
Victor Carregari
FVFlavio Protasio Veras
Flavio Protasio Veras
PVPedro Henrique Vendramini
Pedro Henrique Vendramini
AVAline Gazzola Fragnani Valença
Aline Gazzola Fragnani Valença
MSMaria Ercilia de Paula Castilho Stefano
Maria Ercilia de Paula Castilho Stefano
Although increasing evidence confirms neuropsychiatric manifestations associated mainly with severe COVID-19 infection, the long-term neuropsychiatric dysfunction has been frequently observed after mild infection. Here we show the spectrum of the cerebral impact of SARS-CoV-2 infection ranging from long-term alterations in mildly infected individuals (orbitofrontal cortical atrophy, neurocognitive impairment, excessive fatigue and anxiety symptoms) to severe acute damage confirmed in brain tissue samples extracted from the orbitofrontal region (via endonasal trans-ethmoidal approach) from individuals who died of COVID-19. We used surface-based analyses of 3T MRI and identified orbitofrontal cortical atrophy in a group of 81 mildly infected patients (77% referred anosmia or dysgeusia during acute stage) compared to 145 healthy volunteers; this atrophy correlated with symptoms of anxiety and cognitive dysfunction. In an independent cohort of 26 individuals who died of COVID-19, we used histopathological signs of brain damage as a guide for possible SARS-CoV-2 brain infection, and found that among the 5 individuals who exhibited those signs, all of them had genetic material of the virus in the brain. Brain tissue samples from these 5 patients also exhibited foci of SARS-CoV-2 infection and replication, particularly in astrocytes. Supporting the hypothesis of astrocyte infection, neural stem cell-derived human astrocytes in vitro are susceptible to SARS-CoV-2 infection through a non-canonical mechanism that involves spike-NRP1 interaction. SARS-CoV-2-infected astrocytes manifested changes in energy metabolism and in key proteins and metabolites used to fuel neurons, as well as in the biogenesis of neurotransmitters. Moreover, human astrocyte infection elicits a secretory phenotype that reduces neuronal viability. Our data support the model in which SARS-CoV-2 reaches the brain, infects astrocytes and consequently leads to neuronal death or dysfunction. These deregulated processes are also likely to contribute to the structural and functional alterations seen in the brains of COVID-19 patients.

14 November 2024 in Annals of Neurology
Verified
Journal Article
Open access
MRMathilde Ripart
Mathilde Ripart
JDJordan DeKraker
Jordan DeKraker
MEMaria H. Eriksson
Maria H. Eriksson
RPRory J. Piper
Rory J. Piper
SGSiby Gopinath
Siby Gopinath
MGMELD HS study group
MELD HS study group
Objective: Hippocampal sclerosis (HS), the most common pathology associated with temporal lobe epilepsy (TLE), is not always visible on magnetic resonance imaging (MRI), causing surgical delays and reduced postsurgical seizure‐freedom. We developed an open‐source software to characterize and localize HS to aid the presurgical evaluation of children and adults with suspected TLE.Methods: We included a multicenter cohort of 365 participants (154 HS; 90 disease controls; 121 healthy controls). HippUnfold was used to extract morphological surface‐based features and volumes of the hippocampus from T1‐weighted MRI scans. We characterized pathological hippocampi in patients by comparing them to normative growth charts and analyzing within‐subject feature asymmetries. Feature asymmetry scores were used to train a logistic regression classifier to detect and lateralize HS. The classifier was validated on an independent multicenter cohort of 275 patients with HS and 161 healthy and disease controls.Results: HS was characterized by decreased volume, thickness, and gyrification alongside increased mean and intrinsic curvature. The classifier detected 90.1% of unilateral HS patients and lateralized lesions in 97.4%. In patients with MRI‐negative histopathologically‐confirmed HS, the classifier detected 79.2% (19/24) and lateralized 91.7% (22/24). The model achieved similar performances on the independent cohort, demonstrating its ability to generalize to new data. Individual patient reports contextualize a patient's hippocampal features in relation to normative growth trajectories, visualise feature asymmetries, and report classifier predictions.Interpretation: Automated and Interpretable Detection of Hippocampal Sclerosis (AID‐HS) is an open‐source pipeline for detecting and lateralizing HS and outputting clinically‐relevant reports. ANN NEUROL 2025;97:62–75

24 March 2021 in medRxiv
Verified
Preprint
Open access
PDF file
LSLucas Scardua Silva
Lucas Scardua Silva
RJRafael Batista Joao
Rafael Batista Joao
MNMateus Henrique Nogueira
Mateus Henrique Nogueira
IAItalo Karmann Aventurato
Italo Karmann Aventurato
BCBrunno Machado de Campos
Brunno Machado de Campos
UCUniversity lin Campinas
University lin Campinas
Although post-acute cognitive dysfunction and neuroimaging abnormalities have been reported after hospital discharge in patients recovered from COVID-19, little is known about persistent, long-term alterations in patients who did not require hospitalization. Therefore, we conducted a cross-sectional study of 87 consecutive, non-hospitalized recovered individuals, with a median of 54 days after the laboratory confirmation of COVID-19. We performed structured interviews, neurological examination, and 3T-MRI scans. The MRI study included white matter investigation with diffusion tensor images (DTI) and seed-based resting-state functional MRI (fMRI) connectivity analyses of the default mode network (DMN). In addition, we used validated instruments to examine fatigue, symptoms of anxiety and depression, somnolence, language, memory, and cognitive flexibility. Individuals self-reported a high frequency of headaches (40%) and memory difficulties (33%). The quantitative analyses confirmed symptoms of fatigue (68% of participants), excessive somnolence (35%), symptoms of anxiety (29%), impaired cognitive flexibility (40%) and language dysfunction (33%). In addition, we observed a correlation between DTI fractional anisotropy (FA) and abnormal attention and cognitive flexibility measured by the Trail Making Test part B. The resting-state fMRI study of the DMN showed an association between higher connectivity of the posterior cingulate cortex (PCC) and higher levels of fatigue and somnolence. While greater connectivity of the PCC with bilateral angular gyri was associated with higher fatigue levels, the elevated levels of somnolence correlated with higher connectivity between the PCC and both the left thalamus and putamen.

29 October 2025 in Epilepsia
Verified
Journal Article
Closed access
BSBenjamin Sinclair
Benjamin Sinclair
UCUniversity lin Campinas
University lin Campinas
JNJohn‐Paul Nicolo
John‐Paul Nicolo
GHGernot Hlauschek
Gernot Hlauschek
TBThais Bezerra
Thais Bezerra
MLMeng Law
Meng Law

7 February 2024 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
LPLécio Figueira Pinto
Lécio Figueira Pinto
LSLucas Scárdua Silva
Lucas Scárdua Silva
RJRafael Batista João
Rafael Batista João
VBVinícius Boldrini
Vinícius Boldrini
FCFernando Cendes
Fernando Cendes
UCUniversity lin Campinas
University lin Campinas
The treatment of epilepsy has advanced over the past 30 years through the development of new antiseizure medications (ASMs). Unfortunately, not all of them have been approved yet in Brazil, and many are still underused. When comparing new ASMs to older ones, they are generally not more effective in treating epilepsy. However, they offer better tolerability, with fewer interactions and long-term side effects, especially for patients with comorbidities or those requiring polytherapy. Enzyme induction caused by older ASMs is associated with increased cholesterol levels, drug interactions with decreased effects of statins and other cardiovascular medications, anticoagulants, chemotherapy, immunosuppressors, anti-infective agents (including HIV treatment), antidepressants, and contraceptives. Additionally, they can reduce levels of vitamin D and sex hormones, as well as decrease bone density. The increasing concern about these effects during life, especially after prolonged exposure, has led most developed countries to change prescription patterns in favor of new ASMs, particularly levetiracetam and lamotrigine. Both are also considered the safest options for women of childbearing age. Regrettably, the prescription trends in Brazil have remained largely unchanged over time. This can be partially attributed to the slower approval process of ASM and the reluctance of general physicians and neurologists to embrace these new concepts. In this concise review, we highlight the various advantages linked to the new ASM, aiming to promote a shift in the prescription pattern for ASM. The selection of ASM should be customized according to individual characteristics, and practical suggestions for choosing ASMs are provided in this paper.

23 October 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
RKRebecca Kerestes
Rebecca Kerestes
APAndrew Perry
Andrew Perry
LVLucy Vivash
Lucy Vivash
TOTerence J. O’brien
Terence J. O’brien
MAMarina K.M. Alvim
Marina K.M. Alvim
IHIan H. Harding
Ian H. Harding
Objective: The intricate neuroanatomical structure of the cerebellum is of longstanding interest in epilepsy, but has been poorly characterized within the current cortico-centric models of this disease. We quantified cross-sectional regional cerebellar lobule volumes using structural MRI in 1,602 adults with epilepsy and 1,022 healthy controls across twenty-two sites from the global ENIGMA-Epilepsy working group. Methods: A state-of-the-art deep learning-based approach was employed that parcellates the cerebellum into 28 neuroanatomical subregions. Linear mixed models compared total and regional cerebellar volume in i) all epilepsies; ii) temporal lobe epilepsy with hippocampal sclerosis (TLE-HS); iii) non-lesional temporal lobe epilepsy (TLE-NL); iv) genetic generalised epilepsy; and (v) extra-temporal focal epilepsy (ETLE). Relationships were examined for cerebellar volume versus age at seizure onset, duration of epilepsy, phenytoin treatment, and cerebral cortical thickness. Results: Across all epilepsies, reduced total cerebellar volume was observed ( d =0.42). Maximum volume loss was observed in the corpus medullare ( d max =0.49) and posterior lobe grey matter regions, including bilateral lobules VIIB ( d max = 0.47), Crus I/II ( d max = 0.39), VIIIA ( d max =0.45) and VIIIB ( d max =0.40). Earlier age at seizure onset ( ηρ 2 max =0.05) and longer epilepsy duration ( ηρ 2 max =0.06) correlated with reduced volume in these regions. Findings were most pronounced in TLE-HS and ETLE with distinct neuroanatomical profiles observed in the posterior lobe. Phenytoin treatment was associated with reduced posterior lobe volume. Cerebellum volume correlated with cerebral cortical thinning more strongly in the epilepsy cohort than in controls. Significance: We provide robust evidence of deep cerebellar and posterior lobe subregional grey matter volume loss in patients with chronic epilepsy. Volume loss was maximal for posterior subregions implicated in non-motor functions, relative to motor regions of both the anterior and posterior lobe. Associations between cerebral and cerebellar changes, and variability of neuroanatomical profiles across epilepsy syndromes argue for more precise incorporation of cerebellum subregions into neurobiological models of epilepsy. Key points: Cerebellar involvement in epilepsy is poorly understood within current cortico-centric models of this disease We used a novel, deep learning segmentation tool to parcellate the cerebellum into 28 anatomical subunits using an international MRI dataset of 1,602 individuals with epilepsy (aged between 18 and 65 years old) including temporal lobe epilepsy with hippocampal sclerosis (TLE-HS, n =562), TLE non-lesional (TLE-NL, n =284), generalised genetic epilepsy (GGE, n =186) and extra temporal focal epilepsy (ETLE, n =251) and 1,022 controls. Across all epilepsies (vs. controls) robust changes in the corpus medullare and posterior lobe “non-motor” regions were observed, with maximal differences in bilateral VIIB and Crus II lobules. Lower volume of these regions correlated with longer disease duration. Anterior “motor lobe” regions were relatively spared. Findings were most pronounced in TLE-HS and ETLE groups, with distinct neuroanatomical profiles observed. Cortical thinning was associated with pronounced cerebellar volume loss in TLE-HS epilepsy, relative to controls. ETHICAL PUBLICATION STATEMENT: We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.